Colombo M et al. |
Influence of Drug Brittleness, Nanomilling Time, and Freeze-Drying on the Crystallinity of Poorly Water-Soluble Drugs and Its Implications for Solubility Enhancement. |
2017 |
AAPS PharmSciTech |
pmid:28168626
|
Lim SW et al. |
Ginseng extract reduces tacrolimus-induced oxidative stress by modulating autophagy in pancreatic beta cells. |
2017 |
Lab. Invest. |
pmid:28759009
|
Saliba F et al. |
Efficacy and Safety of Everolimus and Mycophenolic Acid With Early Tacrolimus Withdrawal After Liver Transplantation: A Multicenter Randomized Trial. |
2017 |
Am. J. Transplant. |
pmid:28133906
|
Alloway RR |
Mounting Clinical Evidence With Tacrolimus Generic Products. |
2017 |
Transplantation |
pmid:28749820
|
de Fijter JW et al. |
Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial. |
2017 |
Am. J. Transplant. |
pmid:28027625
|
Willerth SM |
Localized Tacrolimus Delivery Repairs the Damaged Central Nervous System. |
2017 |
EBioMedicine |
pmid:29195745
|
Sopko NA et al. |
Ex Vivo Model of Human Penile Transplantation and Rejection: Implications for Erectile Tissue Physiology. |
2017 |
Eur. Urol. |
pmid:27432525
|
Al-Uzri A et al. |
Longitudinal study on the use of dried blood spots for home monitoring in children after kidney transplantation. |
2017 |
Pediatr Transplant |
pmid:28635157
|
Ma X et al. |
Inhibition effect of tacrolimus and platelet-derived growth factor-BB on restenosis after vascular intimal injury. |
2017 |
Biomed. Pharmacother. |
pmid:28633129
|
Zidan AS |
Taste-masked tacrolimus-phospholipid nanodispersions: dissolution enhancement, taste masking and reduced gastric complications. |
2017 |
Pharm Dev Technol |
pmid:26811031
|
Ueno P et al. |
Wound Healing Complications in Kidney Transplant Recipients Receiving Everolimus. |
2017 |
Transplantation |
pmid:27490418
|
Saburi M et al. |
Effects of calcineurin inhibitors on sodium excretion in recipients of allogeneic hematopoietic stem cell transplantation. |
2017 |
Int. J. Hematol. |
pmid:28516402
|
Ferreira A et al. |
Donor-Specific Anti-Human Leukocyte Antigens Antibodies, Acute Rejection, Renal Function, and Histology in Kidney Transplant Recipients Receiving Tacrolimus and Everolimus. |
2017 |
Am. J. Nephrol. |
pmid:28511172
|
Gu K et al. |
Atypical pneumonia due to human bocavirus in an immunocompromised patient. |
2017 |
CMAJ |
pmid:28507089
|
Kim YJ et al. |
Two cases of hydroa vacciniforme-like lymphoproliferative disease controlled by anti-inflammatory agents. |
2017 |
Photodermatol Photoimmunol Photomed |
pmid:28543883
|
Zong YP et al. |
Effects of CYP3A5 polymorphisms on tacrolimus pharmacokinetics in pediatric kidney transplantation: a systematic review and meta-analysis of observational studies. |
2017 |
World J Pediatr |
pmid:28540692
|
Sanghavi K et al. |
Genotype-guided tacrolimus dosing in African-American kidney transplant recipients. |
2017 |
Pharmacogenomics J. |
pmid:26667830
|
Gnarra M et al. |
Low-Dose Cyclosporine A in the Treatment of Severe Atopic Dermatitis Complicated by Chronic Hepatitis C Virus Infection. |
2017 |
Pediatr Dermatol |
pmid:28382768
|
Undre N and Dickinson J |
Relative bioavailability of single doses of prolonged-release tacrolimus administered as a suspension, orally or via a nasogastric tube, compared with intact capsules: a phase 1 study in healthy participants. |
2017 |
BMJ Open |
pmid:28377389
|
Størset E et al. |
Response to: 'Response to: Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance'. |
2017 |
Br J Clin Pharmacol |
pmid:28374426
|
Zhang H et al. |
Multitarget Therapy for Maintenance Treatment of Lupus Nephritis. |
2017 |
J. Am. Soc. Nephrol. |
pmid:28760751
|
Hettiarachchi PVKS et al. |
Comparison of topical tacrolimus and clobetasol in the management of symptomatic oral lichen planus: A double-blinded, randomized clinical trial in Sri Lanka. |
2017 |
J Investig Clin Dent |
pmid:27633647
|
Wen Y et al. |
Inhibition of Calcineurin A by FK506 Suppresses Seizures and Reduces the Expression of GluN2B in Membrane Fraction. |
2017 |
Neurochem. Res. |
pmid:28299629
|
Forns X et al. |
Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN study. |
2017 |
Transpl Infect Dis |
pmid:28295849
|
Ericzon BG et al. |
Pharmacokinetics of prolonged-release tacrolimus versus immediate-release tacrolimus in de novo liver transplantation: A randomized phase III substudy. |
2017 |
Clin Transplant |
pmid:28295581
|
Lum EL et al. |
Acute Kidney Allograft Rejection Precipitated by Lenalidomide Treatment for Multiple Myeloma. |
2017 |
Am. J. Kidney Dis. |
pmid:28189378
|
Xie Y et al. |
Delayed Donor Bone Marrow Infusion Induces Liver Transplant Tolerance. |
2017 |
Transplantation |
pmid:28187014
|
Smolders EJ et al. |
Decreased tacrolimus plasma concentrations during HCV therapy: a drug-drug interaction or is there an alternative explanation? |
2017 |
Int. J. Antimicrob. Agents |
pmid:28185946
|
Hashemizadeh Z et al. |
Observational Study of Associations between Voriconazole Therapeutic Drug Monitoring, Toxicity, and Outcome in Liver Transplant Patients. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28923870
|
Arroyo Hornero R et al. |
CD45RA Distinguishes CD4+CD25+CD127-/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of Suppression. |
2017 |
Transplantation |
pmid:28118317
|
Liu MZ et al. |
IL-3 and CTLA4 gene polymorphisms may influence the tacrolimus dose requirement in Chinese kidney transplant recipients. |
2017 |
Acta Pharmacol. Sin. |
pmid:28112181
|
Nishiya Y et al. |
A new efficient method of generating photoaffinity beads for drug target identification. |
2017 |
Bioorg. Med. Chem. Lett. |
pmid:28108248
|
Chung BH et al. |
Suppressive Effect of 1α,25-Dihydroxyvitamin D3 on Th17-Immune Responses in Kidney Transplant Recipients With Tacrolimus-Based Immunosuppression. |
2017 |
Transplantation |
pmid:28107277
|
Herskovitz J et al. |
Immune Suppression During Preclinical Drug Development Mitigates Immunogenicity-Mediated Impact on Therapeutic Exposure. |
2017 |
AAPS J |
pmid:28070711
|
Noguchi A et al. |
Differences in therapeutic effects of topically applied corticosteroid and tacrolimus on atopic dermatitis-like symptoms in NC/Nga mice. |
2017 |
J. Dermatol. Sci. |
pmid:28069324
|
Wungwattana M and Savic M |
Tacrolimus interaction with nafcillin resulting in significant decreases in tacrolimus concentrations: A case report. |
2017 |
Transpl Infect Dis |
pmid:28067989
|
MartÃn-Fernández M et al. |
Effects of Cyclosporine, Tacrolimus, and Rapamycin on Osteoblasts. |
2017 |
Transplant. Proc. |
pmid:29149986
|
Ivulich S et al. |
Clinical Challenges of Tacrolimus for Maintenance Immunosuppression Post-Lung Transplantation. |
2017 |
Transplant. Proc. |
pmid:29149976
|
Liberal R et al. |
Expert clinical management of autoimmune hepatitis in the real world. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28004405
|
Nakamura K et al. |
AS2553627, a novel JAK inhibitor, prevents chronic rejection in rat cardiac allografts. |
2017 |
Eur. J. Pharmacol. |
pmid:27993641
|
Goldsmith PM et al. |
Impact of intrapatient variability (IPV) in tacrolimus trough levels on long-term renal transplant function: multicentre collaborative retrospective cohort study protocol. |
2017 |
BMJ Open |
pmid:28756385
|
Lewis DJ et al. |
Oral bexarotene for post-transplant cutaneous T-cell lymphoma. |
2017 |
Dermatol Ther |
pmid:28748653
|
Gelens MACJ et al. |
No evidence for progressive deterioration in stimulated insulin secretion in renal transplant recipients after 12years tacrolimus exposure. |
2017 |
J. Diabetes Complicat. |
pmid:28720321
|
Wan T et al. |
Dual roles of TPGS based microemulsion for tacrolimus: Enhancing the percutaneous delivery and anti-psoriatic efficacy. |
2017 |
Int J Pharm |
pmid:28629978
|
Andrews LM et al. |
Pharmacokinetic considerations related to therapeutic drug monitoring of tacrolimus in kidney transplant patients. |
2017 |
Expert Opin Drug Metab Toxicol |
pmid:29084469
|
Noceti O et al. |
Activity of the Calcineurin Pathway in Patients on the Liver Transplantation Waiting List: Factors of Variability and Response to Tacrolimus Inhibition. |
2017 |
Clin. Chem. |
pmid:29054923
|
Soiffer RJ et al. |
Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation. |
2017 |
J. Clin. Oncol. |
pmid:29040031
|
Theile D et al. |
Clementine juice has the potential for drug interactions - In vitro comparison with grapefruit and mandarin juice. |
2017 |
Eur J Pharm Sci |
pmid:27890698
|
Chen P et al. |
Dynamic effects of CYP3A5 polymorphism on dose requirement and trough concentration of tacrolimus in renal transplant recipients. |
2017 |
J Clin Pharm Ther |
pmid:27885697
|
Grinyó JM et al. |
Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized Trial. |
2017 |
Am. J. Kidney Dis. |
pmid:27889299
|